 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News Go-Ahead for Anti-AIDS Gel TrialsAugust 4, 2003 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! An Australian company has won FDA approval to begin human trials for its microbicide gel. In macaque monkey trials, a single application of VivaGel was 100 percent effective against the monkey version of HIV and the animal versions of genital herpes and chlamydia. Melbourne-based Starpharma will begin phase one human trials of VivaGel by the end of this year. If human trials are successful, the gel will be targeted to women in poorer nations, giving them cheaper, easier control over HIV prevention. A prescription-only gel could be available in three years' time. It would take another two years to produce an over-the-counter version. Countries such as Myanmar and Papua New Guinea face looming AIDS crises similar to the epidemic in Africa due to a lack of preventive measures. At the end of 2002, 42 million people worldwide were HIV-infected; estimates say by 2010, 45 million more people will have HIV. CNN.com 07.31.03; Grant Holloway A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
